IQVIA HOLDINGS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
IQVIA HOLDINGS INC. (IQV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 783.70 thousand shares for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-16.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2017-10-27
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-06-30 was 39.40K shares, a 25.94% decline year-over-year.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-03-31 was 744.30K shares, a 19.42% decline year-over-year.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2016 was 783.70K shares, a 21.13% decline from fiscal 2015.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2015 was 993.60K shares, a 38.74% decline from fiscal 2014.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2014 was 1.62M shares, a 31.37% decline from fiscal 2013.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2013 was 2.36M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|---|---|---|
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | 0.00 shares derived: sum of 2 quarters · filed 2017-10-27 | 39.40K shares derived: sum of 3 quarters · filed 2017-10-27 | 783.70K shares 10-K · filed 2017-02-16 | |||
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | 39.40K shares derived: sum of 2 quarters · filed 2017-10-27 | 783.70K shares 10-Q · filed 2017-10-27 | 790.40K shares derived: sum of 4 quarters · filed 2017-10-27 | |||
| 2016-06-30 | 39.40K shares 10-Q · filed 2017-08-04 | 783.70K shares 10-Q · filed 2017-08-04 | 790.40K shares derived: sum of 3 quarters · filed 2017-08-04 | 800.40K shares derived: sum of 4 quarters · filed 2017-08-04 | |||
| 2016-03-31 | 744.30K shares 10-Q · filed 2017-05-08 | 751.00K shares derived: sum of 2 quarters · filed 2017-05-08 | 761.00K shares derived: sum of 3 quarters · filed 2017-05-08 | 814.20K shares derived: sum of 4 quarters · filed 2017-05-08 | |||
| 2015-12-31 | 6.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | 16.70K shares derived: sum of 2 quarters · filed 2016-11-03 | 69.90K shares derived: sum of 3 quarters · filed 2016-11-03 | 993.60K shares 10-K · filed 2016-02-11 | |||
| 2015-09-30 | 10.00K shares 10-Q · filed 2016-11-03 | 63.20K shares derived: sum of 2 quarters · filed 2016-11-03 | 986.90K shares 10-Q · filed 2016-11-03 | 1.25M shares derived: sum of 4 quarters · filed 2016-11-03 | |||
| 2015-06-30 | 53.20K shares 10-Q · filed 2016-07-27 | 976.90K shares 10-Q · filed 2016-07-27 | 1.24M shares derived: sum of 3 quarters · filed 2016-07-27 | 1.24M shares derived: sum of 4 quarters · filed 2016-07-27 | |||
| 2015-03-31 | 923.70K shares 10-Q · filed 2016-05-03 | 1.19M shares derived: sum of 2 quarters · filed 2016-05-03 | 1.19M shares derived: sum of 3 quarters · filed 2016-05-03 | 1.52M shares derived: sum of 4 quarters · filed 2016-05-03 | |||
| 2014-12-31 | 262.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | 262.40K shares derived: sum of 2 quarters · filed 2015-10-28 | 597.50K shares derived: sum of 3 quarters · filed 2015-10-28 | 1.62M shares 10-K · filed 2015-02-12 | |||
| 2014-09-30 | 0.00 shares 10-Q · filed 2015-10-28 | 335.10K shares derived: sum of 2 quarters · filed 2015-10-28 | 1.36M shares 10-Q · filed 2015-10-28 | 1.52M shares derived: sum of 4 quarters · filed 2015-10-28 | |||
| 2014-06-30 | 335.10K shares 10-Q · filed 2015-07-29 | 1.36M shares 10-Q · filed 2015-07-29 | 1.52M shares derived: sum of 3 quarters · filed 2015-07-29 | 1.62M shares derived: sum of 4 quarters · filed 2015-07-29 | |||
| 2014-03-31 | 1.02M shares 10-Q · filed 2015-04-29 | 1.19M shares derived: sum of 2 quarters · filed 2015-04-29 | 1.29M shares derived: sum of 3 quarters · filed 2015-04-29 | 3.31M shares derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2013-12-31 | 163.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | 263.00K shares derived: sum of 2 quarters · filed 2014-10-30 | 2.29M shares derived: sum of 3 quarters · filed 2014-10-30 | 2.36M shares 10-K · filed 2014-02-13 | |||
| 2013-09-30 | 100.00K shares 10-Q · filed 2014-10-30 | 2.13M shares derived: sum of 2 quarters · filed 2014-10-30 | 2.20M shares 10-Q · filed 2014-10-30 | 2.20M shares 10-Q · filed 2013-10-31 | |||
| 2013-06-30 | 2.03M shares 10-Q · filed 2014-07-31 | 2.03M shares 10-Q · filed 2013-08-01 | 2.10M shares 10-Q · filed 2014-07-31 | 2.10M shares 10-Q · filed 2013-08-01 | |||
| 2013-03-31 | 75.00K shares 10-Q · filed 2014-05-01 | ||||||
| 2012-09-30 | 1.90M shares 10-Q · filed 2013-10-31 | 2.94M shares derived: sum of 2 quarters · filed 2013-10-31 | 2.94M shares 10-Q · filed 2013-10-31 | ||||
| 2012-06-30 | 1.05M shares 10-Q · filed 2013-08-01 | 1.05M shares 10-Q · filed 2013-08-01 | |||||
| 2012-03-31 | 0.00 shares 10-Q · filed 2013-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |